191 related articles for article (PubMed ID: 10554946)
1. Modern antioestrogens and the coming revolution in women's health care.
Evans A; Vollenhoven B; Healy D
Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):334-40. PubMed ID: 10554946
[TBL] [Abstract][Full Text] [Related]
2. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS
J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
Lippman SM; Brown PH
J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
[No Abstract] [Full Text] [Related]
4. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
5. Selective oestrogen receptor modulators--current and future brain and behaviour applications.
Halbreich U; Kahn LS
Expert Opin Pharmacother; 2000 Dec; 1(7):1385-98. PubMed ID: 11249472
[TBL] [Abstract][Full Text] [Related]
6. Progress in the prevention of breast cancer: concept to reality.
Jordan VC
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):269-77. PubMed ID: 11162935
[TBL] [Abstract][Full Text] [Related]
7. A pharmacological review of selective oestrogen receptor modulators.
Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L
Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566
[TBL] [Abstract][Full Text] [Related]
8. Skeletal effects of selective oestrogen receptor modulators (SERMs).
Díez JL
Hum Reprod Update; 2000; 6(3):255-8. PubMed ID: 10874570
[TBL] [Abstract][Full Text] [Related]
9. [Specific estrogen receptor modulators (SERMs)].
Trémollières F; Lopes P
Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
Jordan VC; Gapstur S; Morrow M
J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
Park WC; Jordan VC
Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
[TBL] [Abstract][Full Text] [Related]
12. Approaches targeted to estrogen receptors for treatment of tamoxifen-resistant breast cancer: a brief overview.
Terakawa N
Oncology; 2000; 59 Suppl 1():3-4. PubMed ID: 11096349
[No Abstract] [Full Text] [Related]
13. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
Pinilla L; Barreiro ML; Gonzalez LC; Tena-Sempere M; Aguilar E
J Endocrinol; 2002 Mar; 172(3):441-8. PubMed ID: 11874692
[TBL] [Abstract][Full Text] [Related]
14. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
Robertson JF
Cancer Treat Rev; 2004 Dec; 30(8):695-706. PubMed ID: 15541579
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
Muchmore DB
Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
[TBL] [Abstract][Full Text] [Related]
17. SERMs and cardiovascular disease in women. How do these agents affect risk?
Bush TL; Blumenthal R; Lobo R; Clarkson TB
Postgrad Med; 2001 Mar; Spec No():17-24. PubMed ID: 11296735
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators.
Haskell SG
South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.
Jordan VC
Ann N Y Acad Sci; 2001 Dec; 952():60-72. PubMed ID: 11795444
[TBL] [Abstract][Full Text] [Related]
20. Current status of selective estrogen receptor modulators (SERMs).
Conzen SD
Cancer J; 2003; 9(1):4-14. PubMed ID: 12602762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
